🔎 Trials Near Me

Akèy › Lupus › North Carolina › Durham

Etid klinik pou Lupus nan Durham, NC

12 etid pou Lupus ap chèche patisipan nan sit nan ak bò kote Durham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

Ap rekriteFaz 3
  • Research Site, Durham
Laj 5 a 17 · Tout sèks · Mizajou Sep 30, 2026 · NCT05835310

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

Ap rekriteFaz 1/2
  • Research Site, Chapel Hill · 10 mi lwen
Laj 18 a 70 · Tout sèks · Mizajou Sep 10, 2026 · NCT06897930

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Ap rekriteFaz 1
  • Duke University Medical Center, Durham
Laj 18 a 74 · Tout sèks · Mizajou Sep 10, 2026 · NCT07085104

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

Ap rekriteFaz 1
  • University of North Carolina TraCS Institute - CTRC, Chapel Hill · 10 mi lwen
Laj 18 a 70 · Tout sèks · Mizajou Aug 28, 2026 · NCT06925542

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Ap rekriteFaz 1/2
  • UNC Chapel Hill, Chapel Hill · 10 mi lwen
Laj 18 a 65 · Tout sèks · Mizajou Aug 26, 2026 · NCT06121297

Intervention to Improve Communication and Medication Adherence in Lupus

Ap rekrite
  • Duke University, Durham
Laj 18 a 90 · Tout sèks · Mizajou Aug 17, 2026 · NCT06458075

A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

Ap rekriteFaz 1
  • Duke University, Durham
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT07115745

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

Ap rekriteFaz 1
  • Duke University Health System, Durham
Laj 12 a 70 · Tout sèks · Mizajou May 22, 2026 · NCT06308978

Lupus Landmark Study: A Prospective Registry and Biorepository

Ap rekriteEtid obsèvasyon
  • UNC Chapel Hill, Chapel Hill · 10 mi lwen
Laj 18 a 110 · Tout sèks · Mizajou Apr 15, 2026 · NCT05934149

Duke Lupus Registry

Ap rekriteEtid obsèvasyon
  • Duke University Medical Center, Durham
Laj 18 ak plis · Tout sèks · Mizajou Jan 8, 2026 · NCT00512694

Maternal Autoimmune Disease Research Alliance (MADRA) Registry

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Duke University, Durham
Tout laj · Fanm · Mizajou Jan 8, 2026 · NCT03276923

Etid Lupus nan lòt vil

Lòt etid nan Durham

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.